Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Exelixis Inc (NQ: EXEL ) 25.73 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Aug 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Exelixis Inc < Previous 1 2 3 4 5 6 7 8 9 Next > Biotech Battlefields: 3 Stocks to Watch Amid Wall Street Turmoil July 29, 2023 There is opportunity in a crisis. Key biotech stocks amid turmoil could be the greatest deals on the market today. Via InvestorPlace 2 Biotech Growth Stocks I'd Buy Right Now July 27, 2023 Both drugmakers seem to have a bright future ahead. Via The Motley Fool The 3 Most Undervalued Biotech Stocks to Buy Now: July 2023 July 20, 2023 These are the three bargain biotech stocks showcasing massive upside potential for investors looking to find a position in the sector. Via InvestorPlace 3 No-Brainer Stocks to Buy With $200 Right Now June 21, 2023 A modest amount of money can go a long way when it's invested in game-changing businesses. Via The Motley Fool The Smartest Stocks to Buy With $20 Right Now and Hold Forever May 29, 2023 These companies can take investors on a lucrative ride, and all for the price of a few lattes. Via The Motley Fool 2 Under-the-Radar Biotech Stocks to Buy in 2023 May 24, 2023 Companies that don't make a lot of noise can still make you a lot of money. Via The Motley Fool 8 Analysts Have This to Say About Exelixis May 10, 2023 Via Benzinga Exelixis (EXEL) Q1 2023 Earnings Call Transcript May 10, 2023 EXEL earnings call for the period ending March 31, 2023. Via The Motley Fool Exelixis: Q1 Earnings Insights May 09, 2023 Via Benzinga What 9 Analyst Ratings Have To Say About Exelixis April 12, 2023 Via Benzinga 2 Unstoppable Growth Stocks to Buy in 2023 and Beyond May 20, 2023 Both Axsome Therapeutics and Exelixis have potentially game-changing products in their pipelines. Via The Motley Fool Nasdaq Bear Market: 5 Exceptional Growth Stocks You'll Regret Not Buying on the Dip May 13, 2023 A sizable dip in the innovation-driven Nasdaq Composite is the perfect excuse for investors to pounce on some phenomenal deals. Via The Motley Fool Amid Proxy Challenge From Farallon, Exelixis' Board Member Resigns May 08, 2023 Exelixis Inc's (NASDAQ: EXEL) board member Lance Willsey announced his resignation from the Board, Via Benzinga The Smartest Stocks to Buy With $20 Right Now and Hold Forever April 22, 2023 These cheap stocks have the potential to skyrocket over the long haul. Via The Motley Fool Nasdaq Bear Market: 5 Sensational Growth Stocks You'll Regret Not Buying on the Dip April 22, 2023 Opportunistic investors would be wise to pounce on innovative growth stocks following a 33% decline in the Nasdaq Composite. Via The Motley Fool Why Exelixis Stock Leaped More Than 4% Higher Today March 20, 2023 Oh, how some investors love stock buyback programs. Via The Motley Fool Analyst Ratings for Exelixis March 20, 2023 Via Benzinga 2 Stocks to Buy With Less Than $20 March 10, 2023 Some relatively low-priced shares can be good buys, too. Via The Motley Fool The Latest Analyst Ratings for Exelixis March 03, 2023 Via Benzinga 2 Under-the-Radar Biotech Stocks to Buy in 2023 April 05, 2023 Both companies have game-changing product portfolios that should result in stock price growth. Via The Motley Fool Facebook Turns To Generative AI For Help, FedEx Consolidates, UBS Executives Say Surprise Credit Suisse Deal 'Major Challenge:' Today's Top Stories April 05, 2023 Benzinga Via Benzinga Farallon Capital Might Undertake Proxy Fight Against Exelixis, Nominates Three Directors April 05, 2023 Via Benzinga 2 Incredible Stocks to Buy With Less Than $25 April 04, 2023 Nothing beats a great investment for the price of just a few cups of coffee. Via The Motley Fool Exelixis Stock Shows Rising Relative Price Performance; Still Shy Of Key Benchmark March 27, 2023 In a welcome move, Exelixis stock saw its Relative Strength Rating improve to 73 on Monday, up from 69 a day earlier. Via Investor's Business Daily 3 Beaten-Down Stocks That Could Soar This Year March 18, 2023 These stocks could enjoy big rebounds in 2023. Via The Motley Fool Exelixis Stock Generating Improved Relative Strength Rating March 16, 2023 Exelixis stock saw a welcome improvement to its Relative Strength (RS) Rating on Thursday, with an upgrade from 69 to 76. Via Investor's Business Daily The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector March 15, 2023 To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy. Via InvestorPlace Nasdaq Bear Market: 5 Stunning Growth Stocks You'll Regret Not Buying on the Dip March 11, 2023 A 33% plunge in the previously high-flying Nasdaq Composite is the perfect time for growth investors to pounce on some amazing deals. Via The Motley Fool Benzinga's Top Ratings Upgrades, Downgrades For March 9, 2023 March 09, 2023 Via Benzinga Roche, Exelixis Report Second Flop Out Of Three Trials Evaluating Cabozantinib/Atezolizumab Combo March 03, 2023 Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.